AbbVievsFennec Pharmaceuticals

ABBV and FENC stock compared: price, dividend, valuation and results, from SEC filings.

FENC

Fennec Pharmaceuticals Inc.

$13.45

Value $464M

+0.90%
FENC's page

AbbVie (ABBV) has a market value of $501B and Fennec Pharmaceuticals (FENC) $464M. Over the last year, with dividends, ABBV moved +24.9% and FENC +53.7%. The P/E is 48.7 for ABBV and 330.2 for FENC. Dividend yield: ABBV 2.44%, FENC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$501B

    FENC$464M

    ABBV is 1,081 times FENC

  • Revenue, 12 months

    ABBV$66.0B

    FENC$66M

    ABBV is 995 times FENC

  • Net income, 12 months

    ABBV$10.3B

    FENC$2.0M

    ABBV is 5,100 times FENC

  • Operating margin

    ABBV32.2%

    FENC5.6%

    26.6 points apart

  • ROIC

    ABBV25.7%

    FENC–

  • P/E

    ABBV48.7

    FENC330.2

    FENC is 6.8 times ABBV

  • Dividend yield

    ABBV2.4%

    FENC0.0%

    2.4 points apart

  • 5-year return

    ABBV+189.6%

    FENC+36.5%

    153.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+189.6%

FENC+36.5%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsFENCWith dividends
1 year since November 18, 2025+24.9%Price +21.2%+53.7%Price +53.7%
3 years since November 17, 2023+126.7%+31.4% a yearPrice +105.0%+61.7%+17.4% a yearPrice +61.7%
5 years since November 18, 2021+189.6%+23.7% a yearPrice +142.2%+36.5%+6.4% a yearPrice +36.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieFENCFennec Pharmaceuticals

Valuation

ABBVFENC
Valuation
Price$283.54$13.45
Market value$501B$464M
Enterprise value (EV)$571B–
P/E48.7330.2
P/E, 5-year median57.0–
P/B–9.4
EV/EBIT26.9–
Free cash flow yield3.8%0.7%

Results and growth

ABBVFENC
Results and growth
Revenue, 12 months$66.0B$66M
Net income, 12 months$10.3B$2.0M
Free cash flow, 12 months$18.9B$3.1M
Earnings per share, 12 months$5.81$0.04
Revenue growth, year on year8.6%-6.1%
Revenue growth a year, past+5.9%over 5 years+204.7%over 5 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVFENC
Margins and returns on capital
Gross margin73.7%–
Operating margin32.2%5.6%
Net margin15.7%3.1%
ROIC25.7%–
ROE–6.3%

Balance sheet

ABBVFENC
Balance sheet
Cash$10.8B$49M
Total debt$80.9B–
Net debt / EBITDA3.2–
Interest cover7.1×11.7×

Dividends and buybacks

ABBVFENC
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.6%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or FENC

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Fennec Pharmaceuticals?

By market value, AbbVie ($501B) is about 1,081.2 times Fennec Pharmaceuticals ($464M), at today's prices.

How did ABBV and FENC stock do over the last 5 years?

Since November 18, 2021, ABBV's price moved +142.2% and FENC's +36.5%. With dividends: ABBV +189.6% (+23.7% a year), FENC +36.5% (+6.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or FENC?

The dividend yield at today's price is 2.44% for AbbVie and none for Fennec Pharmaceuticals. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and FENC?

At today's price, the P/E is 48.7 for ABBV and 330.2 for FENC. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AbbVie or Fennec Pharmaceuticals?

Over the last twelve months, the net margin was 15.7% for AbbVie and 3.1% for Fennec Pharmaceuticals, and the operating margin 32.2% and 5.6%. Revenue was $66.0B and $66M.

Which is the better investment, AbbVie or Fennec Pharmaceuticals?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.